Depression is one of the most common mental health conditions in the United States. Around 21 million American adults have a ...

Persistent depressive disorder, known as dysthymia or low-grade depression, is less severe than major depression but more chronic. It occurs twice as often in women as in men. Persistent depressive ...

A recent study published in the journal Molecular Psychiatry provides evidence that an individual’s genetic risk for major depression tends to be higher in those who develop more severe forms of the ...

A recent study published in Nature Medicine suggests that a brief psychedelic experience combined with talk therapy can ...

The novel serotonin norepinephrine reuptake inhibitor (SNRI) ammoxetine may effectively treat major depressive disorder (MDD) while avoiding some side effects common to other antidepressants, new ...

Please provide your email address to receive an email when new articles are posted on . High-definition transcranial direct current stimulation was well tolerated with mild adverse effects. The ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar depression. Clinical trials showed significant symptom improvement and potential ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...

A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets ...